Sign In
Get Clay Free →

Stephen Moran

Going nuclear on cancer at Novartis

Dr. Stephen Moran is a distinguished professional with a diverse educational background and extensive experience in the biopharmaceutical industry.

He pursued his academic journey at prestigious institutions, earning a D.Phil in Biophysics from the University of Oxford's Magdalen College, an MA and M.Sci in Biochemistry from the University of Cambridge's St. John's College, and studied Chemistry at the renowned Massachusetts Institute of Technology.

Dr. Moran has held key roles in various organizations, including his current position as the Global Program Head at Advanced Accelerator Applications, a subsidiary of Novartis.

Prior to his current role, he served as a Guest Lecturer at the University of St.Gallen, Global Head of Strategy at Novartis, Strategic Assistant to the CEO at Novartis, and an Associate Principal at McKinsey & Company.

His expertise spans strategic planning, pharmaceutical innovations, leadership development, and academic instruction, making him a valuable asset to the industry.

Dr. Moran's academic achievements coupled with his professional experiences reflect a well-rounded individual dedicated to making significant contributions to the field of biopharmaceuticals.